CIBC Private Wealth Group
RPRX icon

CIBC Private Wealth Group’s Royalty Pharma RPRX Stock Holding History

CIBC Private Wealth Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$43.2K Buy
1,118
+446
+66% +$17K ﹤0.01% 1849
2025
Q3 		$23.7K Buy
672
+633
+1,623% +$22.9K ﹤0.01% 2097
2025
Q2 		$1.41K Sell
39
-110,921
-100% -$3.67M ﹤0.01% 2717
2025
Q1 		$3.42M Buy
110,960
+1,160
+1% +$36.8K 0.01% 453
2024
Q4 		$2.88M Hold
109,800
– – 0.01% 502
2024
Q3 		$3.11M Sell
109,800
-38
-0% -$1.05K 0.01% 500
2024
Q2 		$2.82M Buy
109,838
+5
+0% +$139 0.01% 489
2024
Q1 		$3.28M Buy
109,833
+32
+0% +$943 0.01% 466
2023
Q4 		$3.08M Sell
109,801
-10
-0% -$275 0.01% 448
2023
Q3 		$2.98M Buy
+109,811
New +$3.26M 0.01% 441
2023
Q1 		– Sell
-12,399
Closed -$490 – 928
2022
Q4 		$490 Hold
12,399
– – ﹤0.01% 794
2022
Q3 		$498K Hold
12,399
– – ﹤0.01% 704
2022
Q2 		$521K Hold
12,399
– – ﹤0.01% 700
2022
Q1 		$483K Buy
12,399
+3,536
+40% +$139K ﹤0.01% 757
2021
Q4 		$353K Buy
+8,863
New +$344K ﹤0.01% 839

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Private Wealth Group's RPRX Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Royalty Pharma (RPRX) stake by 66% in Q4 2025, buying an estimated $17K and bringing the position to 1,118 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

CIBC Private Wealth Group first reported a position in RPRX in Q4 2021 and has held it in 15 quarters since. The position peaked at $3.42M in Q1 2025. 540 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

  • CIBC Private Wealth Group held 1,118 shares of Royalty Pharma worth $43.2K as of Q4 2025.
  • CIBC Private Wealth Group bought 446 Royalty Pharma shares in Q4 2025, an estimated $17K.
  • Royalty Pharma made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1849 holding.
  • CIBC Private Wealth Group first reported a position in Royalty Pharma in Q4 2021 and has held it in 15 quarters since.
  • CIBC Private Wealth Group's Royalty Pharma position peaked at $3.42M in Q1 2025.
  • 540 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.